MoonLake • MLTX
MoonLake Immunotherapeutics is a clinical-stage biotechnology company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Jorge Santos da Silva$2.7B
Market Cap • 25/04/20242020
(há 4 anos)
2022
(2 years ago)
NASDAQ
Listagem
Zug
20
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
MLTXSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.